An Educational Intervention (Lung Toolkit) for Improving Knowledge About Lung Cancer and Screening Among American Indian and Alaskan Native Cigarette Smokers, Lung PATHS Trial
Fred Hutchinson Cancer Center · with Bristol-Myers Squibb · NCT07615764
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 50–80 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 60
- US sites recruiting
- 1
- Study start
- November 1, 2026
- Record last updated
- October 16, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This clinical trial evaluates the acceptability and effectiveness of an educational intervention (Lung Toolkit) for improving knowledge about lung cancer and lung cancer screening among American Indian/Alaskan Native (AI/AN) cigarette smokers. The Lung Toolkit is an educational intervention, including a website and a physical artifact pouch, specifically tailored to the needs of AI/AN individuals. The website includes evidence-based resources about lung health and lung cancer screening, facts about commercial tobacco and traditional tobacco, national and local smoking cessation and screening resources, and community-building resources such as stories from AI/AN community members about their experiences with lung cancer screening and smoking cessation. The physical artifact pouch links to the website with a quick response code and contains ceremonial herbs and motivational messaging around smoking cessation and lung cancer screening. The Lung Toolkit intervention may be effective for improving knowledge about lung cancer and lung cancer screening among AI/AN cigarette smokers.
Being studied: Educational Intervention; Educational Intervention; Interview; Questionnaire Administration
Conditions: Lung Carcinoma
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Between ages 50-80
- Self-identify as AI/AN
- Self-reported 10 pack-year smoking history (commercial tobacco i.e. cigarettes)
- Ability to understand and willingness to sign an informed consent document
Exclusion Criteria
- Not between ages 50-80
- Having less than a 10 pack-year history of smoking commercial tobacco
- Inability to communicate in written and verbal English
- Having any cognitive impairment that compromises the ability to provide informed consent
Recruiting US locations
Fred Hutch/University of Washington Cancer Consortium
Seattle, WA 98109
Site contact: Nicolas Anderson · 206-667-5434 · nanders3@fredhutch.org
Study contacts (from the official record)
- Nicolas Anderson · 206.667.5434 · nanders3@fredhutch.org
Similar studies in Washington
All smoking & vaping studies in Washington →- RecruitingPhase 2
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
Eli Lilly and Company
- Location
- Redmond, WA + 16 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteers
A Digital Intervention (ACT on Vaping App) for Vaping Cessation in Young Adult E-Cigarette Users
Fred Hutchinson Cancer Center
- Location
- Seattle, WA
- Eligibility basics
- Ages 18–30
- RecruitingHealthy volunteers
A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking, IndigeQuit Trial
Fred Hutchinson Cancer Center
- Location
- Seattle, WA
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 2
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
Washington State University
- Location
- Spokane, WA
- Eligibility basics
- Ages 18+